SLC35G6
gene geneOn this page
Summary
SLC35G6 (solute carrier family 35 member G6, HGNC:31351) is a protein-coding gene on chromosome 17p13.1, encoding Solute carrier family 35 member G6 (P0C7Q6).
Predicted to be active in membrane.
Source: NCBI Gene 643664 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 59 total
- MANE Select transcript:
NM_001102614
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31351 |
| Approved symbol | SLC35G6 |
| Name | solute carrier family 35 member G6 |
| Location | 17p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000259224 |
| Ensembl biotype | protein_coding |
| Entrez | 643664 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000412468
RefSeq mRNA: 1 — MANE Select: NM_001102614
NM_001102614
CCDS: CCDS45603
Canonical transcript exons
ENST00000412468 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001657258 | 7481446 | 7481519 |
| ENSE00001797618 | 7481988 | 7483496 |
Expression profiles
Bgee: expression breadth broad, 25 present calls, max score 84.11.
Top tissues by expression
91 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.11 | gold quality |
| right testis | UBERON:0004534 | 62.79 | gold quality |
| left testis | UBERON:0004533 | 62.15 | gold quality |
| testis | UBERON:0000473 | 61.73 | gold quality |
| sural nerve | UBERON:0015488 | 56.38 | silver quality |
| stromal cell of endometrium | CL:0002255 | 55.65 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 53.23 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.68 | gold quality |
| bone marrow cell | CL:0002092 | 49.54 | gold quality |
| granulocyte | CL:0000094 | 47.43 | silver quality |
| muscle tissue | UBERON:0002385 | 46.88 | gold quality |
| bone marrow | UBERON:0002371 | 46.84 | silver quality |
| primary visual cortex | UBERON:0002436 | 45.81 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 44.99 | gold quality |
| tonsil | UBERON:0002372 | 44.49 | gold quality |
| apex of heart | UBERON:0002098 | 43.53 | silver quality |
| blood | UBERON:0000178 | 40.45 | gold quality |
| liver | UBERON:0002107 | 40.11 | gold quality |
| adrenal tissue | UBERON:0018303 | 39.74 | gold quality |
| prefrontal cortex | UBERON:0000451 | 39.10 | silver quality |
| endometrium | UBERON:0001295 | 39.01 | silver quality |
| calcaneal tendon | UBERON:0003701 | 38.92 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 38.88 | silver quality |
| muscle of leg | UBERON:0001383 | 38.65 | silver quality |
| right adrenal gland | UBERON:0001233 | 38.33 | silver quality |
| left adrenal gland cortex | UBERON:0035825 | 37.28 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| myometrium | UBERON:0001296 | 36.16 | silver quality |
| cortex of kidney | UBERON:0001225 | 36.05 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.33 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Slc35g3 | ENSMUSG00000018776 |
| rattus_norvegicus | Slc35g3 | ENSRNOG00000014519 |
| drosophila_melanogaster | CG5281 | FBGN0037902 |
Paralogs (5): SLC35G3 (ENSG00000164729), SLC35G2 (ENSG00000168917), SLC35G1 (ENSG00000176273), SLC35G5 (ENSG00000177710), SLC35G4 (ENSG00000236396)
Protein
Protein identifiers
Solute carrier family 35 member G6 — P0C7Q6 (reviewed: P0C7Q6)
Alternative names: Acyl-malonyl-condensing enzyme 1-like protein 3, Transmembrane protein 21B
All UniProt accessions (1): P0C7Q6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Expressed in placenta and testis.
Miscellaneous. This gene appears to be the source locus of an SVA-mediated retrotransposition event that gave rise to SLC35G3, SLC35G4 and SLC35G5 genes.
Similarity. Belongs to the SLC35G solute transporter family.
RefSeq proteins (1): NP_001096084* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000620 | EamA_dom | Domain |
| IPR037185 | EmrE-like | Homologous_superfamily |
Pfam: PF00892
UniProt features (16 total): transmembrane region 9, sequence variant 3, domain 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0C7Q6-F1 | 82.71 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
MIKKELSEN_ES_ICP_WITH_H3K4ME3, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN, GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN, GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN, GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN, GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN, GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN, GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP, ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE, ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN, GSE27786_LSK_VS_MONO_MAC_DN, GSE27786_LIN_NEG_VS_BCELL_UP, GSE27786_LIN_NEG_VS_MONO_MAC_DN, GSE8835_CD4_VS_CD8_TCELL_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
262 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC35G6 | CDRT15L2 | A8MXV6 | 604 |
| SLC35G6 | A0A3B3IRQ3 | A0A3B3IRQ3 | 590 |
| SLC35G6 | TBC1D28 | Q2M2D7 | 542 |
| SLC35G6 | KRTAP4-8 | Q9BYQ9 | 507 |
| SLC35G6 | CCDC144A | A2RUR9 | 507 |
| SLC35G6 | SPDYE4 | A6NLX3 | 506 |
| SLC35G6 | OR3A2 | P47893 | 505 |
| SLC35G6 | CHCT1 | Q86WR6 | 480 |
| SLC35G6 | TBC1D26 | Q86UD7 | 479 |
| SLC35G6 | TBC1D3G | Q6DHY5 | 476 |
| SLC35G6 | LRRC3C | A6NJW4 | 449 |
| SLC35G6 | POTEC | B2RU33 | 448 |
| SLC35G6 | FBXW10B | O95170 | 448 |
| SLC35G6 | TMEM95 | Q3KNT9 | 447 |
| SLC35G6 | KRTAP4-3 | Q9BYR4 | 447 |
| SLC35G6 | A0A087WT91 | A0A087WT91 | 447 |
| SLC35G6 | TBC1D3B | A6NDS4 | 447 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC35G5 | SLC35G6 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): SLC35G6 (Affinity Capture-MS)
ESM2 similar proteins: A0A0D1DNX1, A0A125YQS6, A0A3S7WQS5, A0A7J6K338, A0A7J6K629, A0A7J6KE60, A4HAG7, A8PRN6, B0K004, C5DGI8, E6ZZ11, G4SDH4, L7WGA7, O76819, O77438, P0C7Q6, P0CM32, P0CM33, P14773, P21441, P42864, Q0C8L9, Q0Q7U9, Q0Q7V0, Q1KKV8, Q2GN49, Q381F9, Q38AH0, Q38BU9, Q3S2U3, Q4D3E8, Q4DKF7, Q4DZ91, Q4HX89, Q4P0S6, Q4X0S3, Q57VW6, Q5F297, Q6C6S3, Q6CGU8
Diamond homologs: B0K004, D3YVE8, P0C7Q5, P0C7Q6, Q0Q7U7, Q0Q7U8, Q0Q7U9, Q0Q7V0, Q5F297, Q5M7A3, Q5ZJZ4, Q8N808, Q8TBE7, Q96KT7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
121 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:7481516:GATG:G | donor_gain | 0.9900 |
| 17:7481513:A:T | donor_gain | 0.9800 |
| 17:7481517:ATGG:A | donor_loss | 0.9800 |
| 17:7481520:G:GA | donor_loss | 0.9800 |
| 17:7481521:TGAG:T | donor_loss | 0.9800 |
| 17:7481522:GAGT:G | donor_loss | 0.9800 |
| 17:7481520:G:GG | donor_gain | 0.9500 |
| 17:7481523:AGTG:A | donor_loss | 0.9500 |
| 17:7481512:G:GT | donor_gain | 0.9400 |
| 17:7481518:TG:T | donor_gain | 0.8500 |
| 17:7481519:GG:G | donor_gain | 0.8500 |
| 17:7481524:G:C | donor_loss | 0.8200 |
| 17:7481982:TAACA:T | acceptor_loss | 0.7900 |
| 17:7481984:ACAG:A | acceptor_loss | 0.7900 |
| 17:7481987:G:A | acceptor_loss | 0.7900 |
| 17:7481987:GGCT:G | acceptor_gain | 0.7800 |
| 17:7481517:ATG:A | donor_gain | 0.7700 |
| 17:7481986:A:AG | acceptor_gain | 0.7700 |
| 17:7481987:G:GG | acceptor_gain | 0.7700 |
| 17:7481986:AGGCT:A | acceptor_gain | 0.7600 |
| 17:7481987:GGCTG:G | acceptor_gain | 0.7600 |
| 17:7481837:TAGGC:T | acceptor_gain | 0.7300 |
| 17:7481515:AGATG:A | donor_gain | 0.7100 |
| 17:7481516:GATGG:G | donor_gain | 0.7100 |
| 17:7481491:G:GT | donor_gain | 0.6900 |
| 17:7482233:T:A | acceptor_gain | 0.6600 |
| 17:7481888:AC:A | acceptor_gain | 0.6400 |
| 17:7481972:CCTTT:C | acceptor_loss | 0.6400 |
| 17:7481973:CTTTC:C | acceptor_loss | 0.6400 |
| 17:7481974:TTTCT:T | acceptor_loss | 0.6400 |
AlphaMissense
2124 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:7482939:A:C | S319R | 0.933 |
| 17:7482941:C:A | S319R | 0.933 |
| 17:7482941:C:G | S319R | 0.933 |
| 17:7482654:T:C | F224L | 0.931 |
| 17:7482656:C:A | F224L | 0.931 |
| 17:7482656:C:G | F224L | 0.931 |
| 17:7482477:A:C | S165R | 0.897 |
| 17:7482479:C:A | S165R | 0.897 |
| 17:7482479:C:G | S165R | 0.897 |
| 17:7482783:T:C | F267L | 0.850 |
| 17:7482785:C:A | F267L | 0.850 |
| 17:7482785:C:G | F267L | 0.850 |
| 17:7482141:T:C | F53L | 0.830 |
| 17:7482143:C:A | F53L | 0.830 |
| 17:7482143:C:G | F53L | 0.830 |
| 17:7482324:A:C | S114R | 0.822 |
| 17:7482326:C:A | S114R | 0.822 |
| 17:7482326:C:G | S114R | 0.822 |
| 17:7482627:T:C | F215L | 0.809 |
| 17:7482629:T:A | F215L | 0.809 |
| 17:7482629:T:G | F215L | 0.809 |
| 17:7482405:T:C | C141R | 0.751 |
| 17:7482936:G:C | G318R | 0.749 |
| 17:7482403:T:A | V140D | 0.733 |
| 17:7482655:T:C | F224S | 0.732 |
| 17:7482850:A:T | E289V | 0.718 |
| 17:7482389:A:C | K135N | 0.708 |
| 17:7482389:A:T | K135N | 0.708 |
| 17:7482937:G:A | G318D | 0.703 |
| 17:7482486:G:A | G168R | 0.700 |
dbSNP variants (sampled 300 via entrez): RS1000442425 (17:7479604 C>A,T), RS1000743261 (17:7481254 T>C), RS1000919990 (17:7483979 A>C), RS1001286903 (17:7483352 GAC>G), RS1003286180 (17:7481132 C>T), RS1003726598 (17:7481326 C>G,T), RS1004590519 (17:7481202 T>C), RS1004642828 (17:7480882 C>T), RS1004696141 (17:7479977 G>A), RS1005116763 (17:7483726 C>CG), RS1007033583 (17:7481868 G>A), RS1007069497 (17:7480394 G>A), RS1007143316 (17:7480587 G>T), RS1007585253 (17:7481550 C>T), RS1008070708 (17:7483714 C>A,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009222_6 | Corpus callosum posterior volume | 8.000000e-06 |
| GCST010002_119 | Refractive error | 3.000000e-22 |
| GCST010703_158 | Brain morphology (MOSTest) | 3.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC35 family of nucleotide sugar transporters
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| 2,6-dichloro-(1,4)benzoquinone | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.